CINXE.COM

<!DOCTYPE html> <html lang="en" dir="ltr"> <head>  <script async src="https://www.googletagmanager.com/gtag/js?id=G-P63WKM1TM1"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-P63WKM1TM1'); </script>  <script type="text/javascript" > (function(m,e,t,r,i,k,a){m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; m[i].l=1*new Date(); for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a)}) (window, document, "script", "https://mc.yandex.ru/metrika/tag.js", "ym"); ym(55165297, "init", { clickmap:false, trackLinks:true, accurateTrackBounce:true, webvisor:false }); </script> <noscript><div><img src="https://mc.yandex.ru/watch/55165297" style="position:absolute; left:-9999px;" alt="" /></div></noscript>    <title>Search results for: mutation testing</title> <meta name="description" content="Search results for: mutation testing"> <meta name="keywords" content="mutation testing"> <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=1, user-scalable=no"> <meta charset="utf-8"> <link href="https://cdn.waset.org/favicon.ico" type="image/x-icon" rel="shortcut icon"> <link href="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/css/bootstrap.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/plugins/fontawesome/css/all.min.css" rel="stylesheet"> <link href="https://cdn.waset.org/static/css/site.css?v=150220211555" rel="stylesheet"> </head> <body> <header> <div class="container"> <nav class="navbar navbar-expand-lg navbar-light"> <a class="navbar-brand" href="https://waset.org"> <img src="https://cdn.waset.org/static/images/wasetc.png" alt="Open Science Research Excellence" title="Open Science Research Excellence" /> </a> <button class="d-block d-lg-none navbar-toggler ml-auto" type="button" data-toggle="collapse" data-target="#navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> <div class="w-100"> <div class="d-none d-lg-flex flex-row-reverse"> <form method="get" action="https://waset.org/search" class="form-inline my-2 my-lg-0"> <input class="form-control mr-sm-2" type="search" placeholder="Search Conferences" value="mutation testing" name="q" aria-label="Search"> <button class="btn btn-light my-2 my-sm-0" type="submit"><i class="fas fa-search"></i></button> </form> </div> <div class="collapse navbar-collapse mt-1" id="navbarMenu"> <ul class="navbar-nav ml-auto align-items-center" id="mainNavMenu"> <li class="nav-item"> <a class="nav-link" href="https://waset.org/conferences" title="Conferences in 2024/2025/2026">Conferences</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/disciplines" title="Disciplines">Disciplines</a> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/committees" rel="nofollow">Committees</a> </li> <li class="nav-item dropdown"> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdownPublications" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> Publications </a> <div class="dropdown-menu" aria-labelledby="navbarDropdownPublications"> <a class="dropdown-item" href="https://publications.waset.org/abstracts">Abstracts</a> <a class="dropdown-item" href="https://publications.waset.org">Periodicals</a> <a class="dropdown-item" href="https://publications.waset.org/archive">Archive</a> </div> </li> <li class="nav-item"> <a class="nav-link" href="https://waset.org/page/support" title="Support">Support</a> </li> </ul> </div> </div> </nav> </div> </header> <main> <div class="container mt-4"> <div class="row"> <div class="col-md-9 mx-auto"> <form method="get" action="https://publications.waset.org/abstracts/search"> <div id="custom-search-input"> <div class="input-group"> <i class="fas fa-search"></i> <input type="text" class="search-query" name="q" placeholder="Author, Title, Abstract, Keywords" value="mutation testing"> <input type="submit" class="btn_search" value="Search"> </div> </div> </form> </div> </div> <div class="row mt-3"> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Commenced</strong> in January 2007</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Frequency:</strong> Monthly</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Edition:</strong> International</div> </div> </div> <div class="col-sm-3"> <div class="card"> <div class="card-body"><strong>Paper Count:</strong> 3235</div> </div> </div> </div> <h1 class="mt-3 mb-3 text-center" style="font-size:1.6rem;">Search results for: mutation testing</h1> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3235</span> Quality and Coverage Assessment in Software Integration Based On Mutation Testing</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Iyad%20Alazzam">Iyad Alazzam</a>, <a href="https://publications.waset.org/abstracts/search?q=Kenneth%20Magel"> Kenneth Magel</a>, <a href="https://publications.waset.org/abstracts/search?q=Izzat%20Alsmadi"> Izzat Alsmadi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The different activities and approaches in software testing try to find the most possible number of errors or failures with the least amount of possible effort. Mutation is a testing approach that is used to discover possible errors in tested applications. This is accomplished through changing one aspect of the software from its original and writes test cases to detect such change or mutation. In this paper, we present a mutation approach for testing software components integration aspects. Several mutation operations related to components integration are described and evaluated. A test case study of several open source code projects is collected. Proposed mutation operators are applied and evaluated. Results showed some insights and information that can help testing activities in detecting errors and improving coverage. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title="software testing">software testing</a>, <a href="https://publications.waset.org/abstracts/search?q=integration%20testing" title=" integration testing"> integration testing</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation" title=" mutation"> mutation</a>, <a href="https://publications.waset.org/abstracts/search?q=coverage" title=" coverage"> coverage</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20design" title=" software design"> software design</a> </p> <a href="https://publications.waset.org/abstracts/5230/quality-and-coverage-assessment-in-software-integration-based-on-mutation-testing" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/5230.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">427</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3234</span> The Effect of Program Type on Mutation Testing: Comparative Study</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=B.%20Falah">B. Falah</a>, <a href="https://publications.waset.org/abstracts/search?q=N.%20E.%20Abakouy"> N. E. Abakouy</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Due to its high computational cost, mutation testing has been neglected by researchers. Recently, many cost and mutants’ reduction techniques have been developed, improved, and experimented, but few of them has relied the possibility of reducing the cost of mutation testing on the program type of the application under test. This paper is a comparative study between four operators’ selection techniques (mutants sampling, class level operators, method level operators, and all operators’ selection) based on the program code type of each application under test. It aims at finding an alternative approach to reveal the effect of code type on mutation testing score. The result of our experiment shows that the program code type can affect the mutation score and that the programs using polymorphism are best suited to be tested with mutation testing. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=equivalent%20mutant" title="equivalent mutant">equivalent mutant</a>, <a href="https://publications.waset.org/abstracts/search?q=killed%20mutant" title=" killed mutant"> killed mutant</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation%20score" title=" mutation score"> mutation score</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation%20testing" title=" mutation testing"> mutation testing</a>, <a href="https://publications.waset.org/abstracts/search?q=program%20code%20type" title=" program code type"> program code type</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title=" software testing"> software testing</a> </p> <a href="https://publications.waset.org/abstracts/34959/the-effect-of-program-type-on-mutation-testing-comparative-study" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/34959.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">555</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3233</span> Machine Learning Approach for Mutation Testing</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Michael%20Stewart">Michael Stewart</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Mutation testing is a type of software testing proposed in the 1970s where program statements are deliberately changed to introduce simple errors so that test cases can be validated to determine if they can detect the errors. Test cases are executed against the mutant code to determine if one fails, detects the error and ensures the program is correct. One major issue with this type of testing was it became intensive computationally to generate and test all possible mutations for complex programs. This paper used reinforcement learning and parallel processing within the context of mutation testing for the selection of mutation operators and test cases that reduced the computational cost of testing and improved test suite effectiveness. Experiments were conducted using sample programs to determine how well the reinforcement learning-based algorithm performed with one live mutation, multiple live mutations and no live mutations. The experiments, measured by mutation score, were used to update the algorithm and improved accuracy for predictions. The performance was then evaluated on multiple processor computers. With reinforcement learning, the mutation operators utilized were reduced by 50 – 100%. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=automated-testing" title="automated-testing">automated-testing</a>, <a href="https://publications.waset.org/abstracts/search?q=machine%20learning" title=" machine learning"> machine learning</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation%20testing" title=" mutation testing"> mutation testing</a>, <a href="https://publications.waset.org/abstracts/search?q=parallel%20processing" title=" parallel processing"> parallel processing</a>, <a href="https://publications.waset.org/abstracts/search?q=reinforcement%20learning" title=" reinforcement learning"> reinforcement learning</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20engineering" title=" software engineering"> software engineering</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title=" software testing"> software testing</a> </p> <a href="https://publications.waset.org/abstracts/141195/machine-learning-approach-for-mutation-testing" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/141195.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">198</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3232</span> Prioritization of Mutation Test Generation with Centrality Measure</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Supachai%20Supmak">Supachai Supmak</a>, <a href="https://publications.waset.org/abstracts/search?q=Yachai%20Limpiyakorn"> Yachai Limpiyakorn</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Mutation testing can be applied for the quality assessment of test cases. Prioritization of mutation test generation has been a critical element of the industry practice that would contribute to the evaluation of test cases. The industry generally delivers the product under the condition of time to the market and thus, inevitably sacrifices software testing tasks, even though many test cases are required for software verification. This paper presents an approach of applying a social network centrality measure, PageRank, to prioritize mutation test generation. The source code with the highest values of PageRank will be focused first when developing their test cases as these modules are vulnerable to defects or anomalies which may cause the consequent defects in many other associated modules. Moreover, the approach would help identify the reducible test cases in the test suite, still maintaining the same criteria as the original number of test cases. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title="software testing">software testing</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation%20test" title=" mutation test"> mutation test</a>, <a href="https://publications.waset.org/abstracts/search?q=network%20centrality%20measure" title=" network centrality measure"> network centrality measure</a>, <a href="https://publications.waset.org/abstracts/search?q=test%20case%20prioritization" title=" test case prioritization"> test case prioritization</a> </p> <a href="https://publications.waset.org/abstracts/154408/prioritization-of-mutation-test-generation-with-centrality-measure" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/154408.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">112</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3231</span> Minimizing Mutant Sets by Equivalence and Subsumption</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Samia%20Alblwi">Samia Alblwi</a>, <a href="https://publications.waset.org/abstracts/search?q=Amani%20Ayad"> Amani Ayad</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Mutation testing is the art of generating syntactic variations of a base program and checking whether a candidate test suite can identify all the mutants that are not semantically equivalent to the base: this technique is widely used by researchers to select quality test suites. One of the main obstacles to the widespread use of mutation testing is cost: even small pro-grams (a few dozen lines of code) can give rise to a large number of mutants (up to hundreds): this has created an incentive to seek to reduce the number of mutants while preserving their collective effectiveness. Two criteria have been used to reduce the size of mutant sets: equiva-lence, which aims to partition the set of mutants into equivalence classes modulo semantic equivalence, and selecting one representative per class; subsumption, which aims to define a partial ordering among mutants that ranks mutants by effectiveness and seeks to select maximal elements in this ordering. In this paper we analyze these two policies using analytical and em-pirical criteria. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=mutation%20testing" title="mutation testing">mutation testing</a>, <a href="https://publications.waset.org/abstracts/search?q=mutant%20sets" title=" mutant sets"> mutant sets</a>, <a href="https://publications.waset.org/abstracts/search?q=mutant%20equivalence" title=" mutant equivalence"> mutant equivalence</a>, <a href="https://publications.waset.org/abstracts/search?q=mutant%20subsumption" title=" mutant subsumption"> mutant subsumption</a>, <a href="https://publications.waset.org/abstracts/search?q=mutant%20set%20minimization" title=" mutant set minimization"> mutant set minimization</a> </p> <a href="https://publications.waset.org/abstracts/156274/minimizing-mutant-sets-by-equivalence-and-subsumption" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/156274.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">63</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3230</span> MCERTL: Mutation-Based Correction Engine for Register-Transfer Level Designs</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Khaled%20Salah">Khaled Salah</a> </p> <p class="card-text"><strong>Abstract:</strong></p> In this paper, we present MCERTL (mutation-based correction engine for RTL designs) as an automatic error correction technique based on mutation analysis. A mutation-based correction methodology is proposed to automatically fix the erroneous RTL designs. The proposed strategy combines the processes of mutation and assertion-based localization. The erroneous statements are mutated to produce possible fixes for the failed RTL code. A concurrent mutation engine is proposed to mitigate the computational cost of running sequential mutants operators. The proposed methodology is evaluated against some benchmarks. The experimental results demonstrate that our proposed method enables us to automatically locate and correct multiple bugs at reasonable time. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=bug%20localization" title="bug localization">bug localization</a>, <a href="https://publications.waset.org/abstracts/search?q=error%20correction" title=" error correction"> error correction</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation" title=" mutation"> mutation</a>, <a href="https://publications.waset.org/abstracts/search?q=mutants" title=" mutants"> mutants</a> </p> <a href="https://publications.waset.org/abstracts/80068/mcertl-mutation-based-correction-engine-for-register-transfer-level-designs" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/80068.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">280</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3229</span> Atypical Familial Amyotrophic Lateral Sclerosis Secondary to Superoxide Dismutase 1 Gene Mutation With Coexistent Axonal Polyneuropathy: A Challenging Diagnosis</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Seraj%20Makkawi">Seraj Makkawi</a>, <a href="https://publications.waset.org/abstracts/search?q=Abdulaziz%20A.%20Alqarni"> Abdulaziz A. Alqarni</a>, <a href="https://publications.waset.org/abstracts/search?q=Himyan%20Alghaythee"> Himyan Alghaythee</a>, <a href="https://publications.waset.org/abstracts/search?q=Suzan%20Y.%20Alharbi"> Suzan Y. Alharbi</a>, <a href="https://publications.waset.org/abstracts/search?q=Anmar%20Fatani"> Anmar Fatani</a>, <a href="https://publications.waset.org/abstracts/search?q=Reem%20Adas"> Reem Adas</a>, <a href="https://publications.waset.org/abstracts/search?q=Ahmad%20R.%20Abuzinadah"> Ahmad R. Abuzinadah</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that involves both the upper and lower motor neurons. Familial ALS, including superoxide dismutase 1 (SOD1) mutation, accounts for 5-10% of all cases of ALS. Typically, the symptoms of ALS are purely motor, though coexistent sensory symptoms have been reported in rare cases. In this report, we describe the case of a 47- year-old man who presented with progressive bilateral lower limb weakness and numbness for the last four years. A nerve conduction study (NCS) showed evidence of coexistent axonal sensorimotor polyneuropathy in addition to the typical findings of ALS in needle electromyography. Genetic testing confirmed the diagnosis of familial ALS secondary to the SOD1 genetic mutation. This report highlights that the presence of sensory symptoms should not exclude the possibility of ALS in an appropriate clinical setting. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Saudi%20Arabia" title="Saudi Arabia">Saudi Arabia</a>, <a href="https://publications.waset.org/abstracts/search?q=polyneuropathy" title=" polyneuropathy"> polyneuropathy</a>, <a href="https://publications.waset.org/abstracts/search?q=SOD1%20gene%20mutation" title=" SOD1 gene mutation"> SOD1 gene mutation</a>, <a href="https://publications.waset.org/abstracts/search?q=familial%20amyotrophic%20lateral%20sclerosis" title=" familial amyotrophic lateral sclerosis"> familial amyotrophic lateral sclerosis</a>, <a href="https://publications.waset.org/abstracts/search?q=amyotrophic%20lateral%20sclerosis" title=" amyotrophic lateral sclerosis"> amyotrophic lateral sclerosis</a> </p> <a href="https://publications.waset.org/abstracts/148506/atypical-familial-amyotrophic-lateral-sclerosis-secondary-to-superoxide-dismutase-1-gene-mutation-with-coexistent-axonal-polyneuropathy-a-challenging-diagnosis" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/148506.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">148</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3228</span> Mutation Analysis of the ATP7B Gene in 43 Vietnamese Wilson’s Disease Patients</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Huong%20M.%20T.%20Nguyen">Huong M. T. Nguyen</a>, <a href="https://publications.waset.org/abstracts/search?q=Hoa%20A.%20P.%20Nguyen"> Hoa A. P. Nguyen</a>, <a href="https://publications.waset.org/abstracts/search?q=Mai%20P.%20T.%20Nguyen"> Mai P. T. Nguyen</a>, <a href="https://publications.waset.org/abstracts/search?q=Ngoc%20D.%20Ngo"> Ngoc D. Ngo</a>, <a href="https://publications.waset.org/abstracts/search?q=Van%20T.%20Ta"> Van T. Ta</a>, <a href="https://publications.waset.org/abstracts/search?q=Hai%20T.%20Le"> Hai T. Le</a>, <a href="https://publications.waset.org/abstracts/search?q=Chi%20V.%20Phan"> Chi V. Phan</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Wilson’s disease (WD) is an autosomal recessive disorder of the copper metabolism, which is caused by a mutation in the copper-transporting P-type ATPase (<em>ATP7B</em>). The mechanism of this disease is the failure of hepatic excretion of copper to bile, and leads to copper deposits in the liver and other organs. The <em>ATP7B</em> gene is located on the long arm of chromosome 13 (13q14.3). This study aimed to investigate the gene mutation in the Vietnamese patients with WD, and make a presymptomatic diagnosis for their familial members. Forty-three WD patients and their 65 siblings were identified as having <em>ATP7B</em> gene mutations. Genomic DNA was extracted from peripheral blood samples; 21 exons and exon-intron boundaries of the <em>ATP7B</em> gene were analyzed by direct sequencing. We recognized four mutations ([R723=; H724Tfs*34], V1042Cfs*79, D1027H, and IVS6+3A>G) in the sum of 20 detectable mutations, accounting for 87.2% of the total. Mutation S105* was determined to have a high rate (32.6%) in this study. The hotspot regions of <em>ATP7B</em> were found at exons 2, 16, and 8, and intron 14, in 39.6 %, 11.6 %, 9.3%, and 7 % of patients, respectively. Among nine homozygote/compound heterozygote siblings of the patients with WD, three individuals were determined as asymptomatic by screening mutations of the probands. They would begin treatment after diagnosis. In conclusion, 20 different mutations were detected in 43 WD patients. Of this number, four novel mutations were explored, including [R723=; H724Tfs*34], V1042Cfs*79, D1027H, and IVS6+3A>G. The mutation S105* is the most prevalent and has been considered as a biomarker that can be used in a rapid detection assay for diagnosis of WD patients. Exons 2, 8, and 16, and intron 14 should be screened initially for WD patients in Vietnam. Based on risk profile for WD, genetic testing for presymptomatic patients is also useful in diagnosis and treatment. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=ATP7B%20gene" title="ATP7B gene">ATP7B gene</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation%20detection" title=" mutation detection"> mutation detection</a>, <a href="https://publications.waset.org/abstracts/search?q=presymptomatic%20diagnosis" title=" presymptomatic diagnosis"> presymptomatic diagnosis</a>, <a href="https://publications.waset.org/abstracts/search?q=Vietnamese%20Wilson%E2%80%99s%20disease" title=" Vietnamese Wilson’s disease"> Vietnamese Wilson’s disease</a> </p> <a href="https://publications.waset.org/abstracts/58250/mutation-analysis-of-the-atp7b-gene-in-43-vietnamese-wilsons-disease-patients" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/58250.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">380</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3227</span> Application of ATP7B Gene Mutation Analysis in Prenatal Diagnosis of Wilson’s Disease</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Huong%20M.%20T.%20Nguyen">Huong M. T. Nguyen</a>, <a href="https://publications.waset.org/abstracts/search?q=Hoa%20A.%20P.%20Nguyen"> Hoa A. P. Nguyen</a>, <a href="https://publications.waset.org/abstracts/search?q=Chi%20V.%20Phan"> Chi V. Phan</a>, <a href="https://publications.waset.org/abstracts/search?q=Mai%20P.%20T.%20Nguyen"> Mai P. T. Nguyen</a>, <a href="https://publications.waset.org/abstracts/search?q=Ngoc%20D.%20Ngo"> Ngoc D. Ngo</a>, <a href="https://publications.waset.org/abstracts/search?q=Van%20T.%20Ta"> Van T. Ta</a>, <a href="https://publications.waset.org/abstracts/search?q=Hai%20T.%20Le"> Hai T. Le</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Wilson’s disease is an autosomal recessive disorder of copper metabolism, which is caused by mutation in copper- transporting P-type ATPase (ATP7B). The mechanism of this disease is a failure of hepatic excretion of copper to the bile, and it leads to copper deposits in the liver and other organs. Most clinical symptoms of Wilson’s disease can present as liver disease and/or neurologic disease. Objective: The goal of the study is prenatal diagnosis for pregnant women at high risk of Wilson’s disease in Northern Vietnam. Material and method: Three probands with clinically diagnosed liver disease were detected in the mutations of 21 exons and exon-intron boundaries of the ATP7B gene by direct Sanger-sequencing. Prenatal diagnoses were performed by amniotic fluid sampling from pregnant women in the 16th-18th weeks of pregnancy after the genotypes of parents with the probands were identified. Result: A total of three different mutations of the probands, including of S105*, P1052L, P1273G, were detected. Among three fetuses which underwent prenatal genetic testing, one fetus was homozygote; two fetuses were carriers. Conclusion: Genetic testing provided a useful method for prenatal diagnosis, and is a basis for genetic counseling. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=ATP7B%20gene" title="ATP7B gene">ATP7B gene</a>, <a href="https://publications.waset.org/abstracts/search?q=genetic%20testing" title=" genetic testing"> genetic testing</a>, <a href="https://publications.waset.org/abstracts/search?q=prenatal%20diagnosis" title=" prenatal diagnosis"> prenatal diagnosis</a>, <a href="https://publications.waset.org/abstracts/search?q=pedigree" title=" pedigree"> pedigree</a>, <a href="https://publications.waset.org/abstracts/search?q=Wilson%20disease" title=" Wilson disease"> Wilson disease</a> </p> <a href="https://publications.waset.org/abstracts/58248/application-of-atp7b-gene-mutation-analysis-in-prenatal-diagnosis-of-wilsons-disease" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/58248.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">455</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3226</span> A Microfluidic Biosensor for Detection of EGFR 19 Deletion Mutation Targeting Non-Small Cell Lung Cancer on Rolling Circle Amplification</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ji%20Su%20Kim">Ji Su Kim</a>, <a href="https://publications.waset.org/abstracts/search?q=Bo%20Ram%20Choi"> Bo Ram Choi</a>, <a href="https://publications.waset.org/abstracts/search?q=Ju%20Yeon%20Cho"> Ju Yeon Cho</a>, <a href="https://publications.waset.org/abstracts/search?q=Hyukjin%20Lee"> Hyukjin Lee</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Epidermal growth factor receptor (EGFR) 19 deletion mutation gene is over-expressed in carcinoma patient. EGFR 19 deletion mutation is known as typical biomarker of non-small cell lung cancer (NSCLC), which one section in the coding exon 19 of EGFR is deleted. Therefore, there have been many attempts over the years to detect EGFR 19 deletion mutation for replacing conventional diagnostic method such as PCR and tissue biopsy. We developed a simple and facile detection platform based on Rolling Circle Amplification (RCA), which provides highly amplified products in isothermal amplification of the ligated DNA template. Limit of detection (~50 nM) and a faster detection time (~30 min) could be achieved by introducing RCA. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=EGFR19" title="EGFR19">EGFR19</a>, <a href="https://publications.waset.org/abstracts/search?q=cancer" title=" cancer"> cancer</a>, <a href="https://publications.waset.org/abstracts/search?q=diagnosis" title=" diagnosis"> diagnosis</a>, <a href="https://publications.waset.org/abstracts/search?q=rolling%20circle%20amplification%20%28RCA%29" title=" rolling circle amplification (RCA)"> rolling circle amplification (RCA)</a>, <a href="https://publications.waset.org/abstracts/search?q=hydrogel" title=" hydrogel"> hydrogel</a> </p> <a href="https://publications.waset.org/abstracts/72641/a-microfluidic-biosensor-for-detection-of-egfr-19-deletion-mutation-targeting-non-small-cell-lung-cancer-on-rolling-circle-amplification" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/72641.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">255</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3225</span> Altered TP53 Mutations in de Novo Acute Myeloid Leukemia Patients in Iran</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Naser%20Shagerdi%20Esmaeli">Naser Shagerdi Esmaeli</a>, <a href="https://publications.waset.org/abstracts/search?q=Mohsen%20Hamidpour"> Mohsen Hamidpour</a>, <a href="https://publications.waset.org/abstracts/search?q=Parisa%20Hasankhani%20Tehrani"> Parisa Hasankhani Tehrani</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background: The TP53 mutation is frequently detected in acute myeloid leukemia (AML) patients with complex karyotype (CK), but the stability of this mutation during the clinical course remains unclear. Material and Methods: In this study, TP53 mutations were identified in 7% of 500 patients with de novo AML and 58.8% of patients with CK in Tabriz, Iran. TP53 mutations were closely associated with older age, lower white blood cell (WBC) and platelet counts, FAB M6 subtype, unfavorable-risk cytogenetics, and CK, but negatively associated with NPM1 mutation, FLT3/ITD and DNMT3A mutation. Result: Multivariate analysis demonstrated that TP53 mutation was an independent poor prognostic factor for overall survival and disease-free survival among the total cohort and the subgroup of patients with CK. A scoring system incorporating TP53 mutation and nine other prognostic factors, including age, WBC counts, cytogenetics, and gene mutations, into survival analysis proved to be very useful to stratify AML patients. Sequential study of 420 samples showed that TP53 mutations were stable during AML evolution, whereas the mutation was acquired only in 1 of the 126 TP53 wild-type patients when therapy-related AML originated from different clone emerged. Conclusion: In conclusion, TP53 mutations are associated with distinct clinic-biological features and poor prognosis in de novo AML patients and are rather stable during disease progression. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=acute%20myloblastic%20leukemia" title="acute myloblastic leukemia">acute myloblastic leukemia</a>, <a href="https://publications.waset.org/abstracts/search?q=TP53" title=" TP53"> TP53</a>, <a href="https://publications.waset.org/abstracts/search?q=FLT3%2FITD" title=" FLT3/ITD"> FLT3/ITD</a>, <a href="https://publications.waset.org/abstracts/search?q=Iran" title=" Iran"> Iran</a> </p> <a href="https://publications.waset.org/abstracts/158096/altered-tp53-mutations-in-de-novo-acute-myeloid-leukemia-patients-in-iran" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/158096.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">107</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3224</span> Mutations in rpoB, katG and inhA Genes: The Association with Resistance to Rifampicin and Isoniazid in Egyptian Mycobacterium tuberculosis Clinical Isolates</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ayman%20K.%20El%20Essawy">Ayman K. El Essawy</a>, <a href="https://publications.waset.org/abstracts/search?q=Amal%20M.%20Hosny"> Amal M. Hosny</a>, <a href="https://publications.waset.org/abstracts/search?q=Hala%20M.%20Abu%20Shady"> Hala M. Abu Shady</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The rapid detection of TB and drug resistance, both optimizes treatment and improves outcomes. In the current study, respiratory specimens were collected from 155 patients. Conventional susceptibility testing and MIC determination were performed for rifampicin (RIF) and isoniazid (INH). Genotype MTBDRplus assay, which is a molecular genetic assay based on the DNA-STRIP technology and specific gene sequencing with primers for rpoB, KatG, and mab-inhA genes were used to detect mutations associated with resistance to rifampicin and isoniazid. In comparison to other categories, most of rifampicin resistant (61.5%) and isoniazid resistant isolates (47.1%) were from patients relapsed in treatment. The genotypic profile (using Genotype MTBDRplus assay) of multi-drug resistant (MDR) isolates showed missing of katG wild type 1 (WT1) band and appearance of mutation band katG MUT2. For isoniazid mono-resistant isolates, 80% showed katG MUT1, 20% showed katG MUT1, and inhA MUT1, 20% showed only inhA MUT1. Accordingly, 100% of isoniazid resistant strains were detected by this assay. Out of 17 resistant strains, 16 had mutation bands for katG distinguished high resistance to isoniazid. The assay could clearly detect rifampicin resistance among 66.7% of MDR isolates that showed mutation band rpoB MUT3 while 33.3% of them were considered as unknown. One mono-resistant rifampicin isolate did not show rifampicin mutation bands by Genotype MTBDRplus assay, but it showed an unexpected mutation in Codon 531 of rpoB by DNA sequence analysis. Rifampicin resistance in this strain could be associated with a mutation in codon 531 of rpoB (based on molecular sequencing), and Genotype MTBDRplus assay could not detect the associated mutation. If the results of Genotype MTBDRplus assay and sequencing were combined, this strain shows hetero-resistance pattern. Gene sequencing of eight selected isolates, previously tested by Genotype MTBDRplus assay, could detect resistance mutations mainly in codon 315 (katG gene), position -15 in inhA promotes gene for isoniazid resistance and codon 531 (rpoB gene) for rifampicin resistance. Genotyping techniques allow distinguishing between recurrent cases of reinfection or reactivation and supports epidemiological studies. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=M.%20tuberculosis" title="M. tuberculosis">M. tuberculosis</a>, <a href="https://publications.waset.org/abstracts/search?q=rpoB" title=" rpoB"> rpoB</a>, <a href="https://publications.waset.org/abstracts/search?q=KatG" title=" KatG"> KatG</a>, <a href="https://publications.waset.org/abstracts/search?q=inhA" title=" inhA"> inhA</a>, <a href="https://publications.waset.org/abstracts/search?q=genotype%20MTBDRplus" title=" genotype MTBDRplus"> genotype MTBDRplus</a> </p> <a href="https://publications.waset.org/abstracts/115843/mutations-in-rpob-katg-and-inha-genes-the-association-with-resistance-to-rifampicin-and-isoniazid-in-egyptian-mycobacterium-tuberculosis-clinical-isolates" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/115843.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">167</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3223</span> Effect of SCN5A Gene Mutation in Endocardial Cell</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Helan%20Satish">Helan Satish</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20Ramasubba%20Reddy"> M. Ramasubba Reddy</a> </p> <p class="card-text"><strong>Abstract:</strong></p> The simulation of an endocardial cell for gene mutation in the cardiac sodium ion channel NaV1.5, encoded by SCN5A gene, is discussed. The characterization of Brugada Syndrome by loss of function effect on SCN5A mutation due to L812Q mutant present in the DII-S4 transmembrane region of the NaV1.5 channel protein and its effect in an endocardial cell is studied. Ten Tusscher model of human ventricular action potential is modified to incorporate the changes contributed by L812Q mutant in the endocardial cells. Results show that BrS-associated SCN5A mutation causes reduction in the inward sodium current by modifications in the channel gating dynamics such as delayed activation, enhanced inactivation, and slowed recovery from inactivation in the endocardial cell. A decrease in the inward sodium current was also observed, which affects depolarization phase (Phase 0) that leads to reduction in the spike amplitude of the cardiac action potential. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=SCN5A%20gene%20mutation" title="SCN5A gene mutation">SCN5A gene mutation</a>, <a href="https://publications.waset.org/abstracts/search?q=sodium%20channel" title=" sodium channel"> sodium channel</a>, <a href="https://publications.waset.org/abstracts/search?q=Brugada%20syndrome" title=" Brugada syndrome"> Brugada syndrome</a>, <a href="https://publications.waset.org/abstracts/search?q=cardiac%20arrhythmia" title=" cardiac arrhythmia"> cardiac arrhythmia</a>, <a href="https://publications.waset.org/abstracts/search?q=action%20potential" title=" action potential"> action potential</a> </p> <a href="https://publications.waset.org/abstracts/126001/effect-of-scn5a-gene-mutation-in-endocardial-cell" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/126001.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">126</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3222</span> The Effects of Androgen Receptor Mutation on Cryptorchid Testes in 46, XY Female </h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Ihtisham%20Bukhari">Ihtisham Bukhari</a> </p> <p class="card-text"><strong>Abstract:</strong></p> In the current study, we enrolled a 46, XY phenotypically female patient bearing testes in her inguinal canal. DNA sequencing of the AR gene detected a missense mutation C.1715A > G (p. Y572C) in exon 2 which is already known to cause Complete androgen insensitivity syndrome (CAIS). We further studied the effects of this mutation on the testicular histopathology of the patient. No spermatocytes were seen in the surface spreading of testicular tissues while H&E staining showed that seminiferous tubules predominantly have only Sertoli cells. To confirm this meiotic failure is likely due to the current AR mutation we performed mRNA expression of genes associated with AR pathway, expression and location of the associated proteins in testicular tissues. Western blot and real-time PCR data showed that the patient had high levels of expression of AMH, SOX9, and INNB in testis. Tubules were stained with SOX9 and AMH which revealed Sertoli cell maturation arrest. Therefore, we suggest that AR mutation enhances AMH expression which ultimately leads to failure in the maturation of Sertoli cells and failure in spermatogenesis. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=androgen%20receptor" title="androgen receptor">androgen receptor</a>, <a href="https://publications.waset.org/abstracts/search?q=spermatogenesis" title=" spermatogenesis"> spermatogenesis</a>, <a href="https://publications.waset.org/abstracts/search?q=infertility" title=" infertility"> infertility</a>, <a href="https://publications.waset.org/abstracts/search?q=Sertoli%20cell%20only%20syndrome" title=" Sertoli cell only syndrome"> Sertoli cell only syndrome</a> </p> <a href="https://publications.waset.org/abstracts/90798/the-effects-of-androgen-receptor-mutation-on-cryptorchid-testes-in-46-xy-female" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/90798.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">143</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3221</span> A Study on Stochastic Integral Associated with Catastrophes</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=M.%20Reni%20Sagayaraj">M. Reni Sagayaraj</a>, <a href="https://publications.waset.org/abstracts/search?q=S.%20Anand%20Gnana%20Selvam"> S. Anand Gnana Selvam</a>, <a href="https://publications.waset.org/abstracts/search?q=R.%20Reynald%20Susainathan"> R. Reynald Susainathan</a> </p> <p class="card-text"><strong>Abstract:</strong></p> We analyze stochastic integrals associated with a mutation process. To be specific, we describe the cell population process and derive the differential equations for the joint generating functions for the number of mutants and their integrals in generating functions and their applications. We obtain first-order moments of the processes of the two-way mutation process in first-order moment structure of X (t) and Y (t) and the second-order moments of a one-way mutation process. In this paper, we obtain the limiting behaviour of the integrals in limiting distributions of X (t) and Y (t). <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=stochastic%20integrals" title="stochastic integrals">stochastic integrals</a>, <a href="https://publications.waset.org/abstracts/search?q=single%E2%80%93server%20queue%20model" title=" single–server queue model"> single–server queue model</a>, <a href="https://publications.waset.org/abstracts/search?q=catastrophes" title=" catastrophes"> catastrophes</a>, <a href="https://publications.waset.org/abstracts/search?q=busy%20period" title=" busy period"> busy period</a> </p> <a href="https://publications.waset.org/abstracts/21325/a-study-on-stochastic-integral-associated-with-catastrophes" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/21325.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">642</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3220</span> Prevalence of Pretreatment Drug HIV-1 Mutations in Moscow, Russia</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Daria%20Zabolotnaya">Daria Zabolotnaya</a>, <a href="https://publications.waset.org/abstracts/search?q=Svetlana%20Degtyareva"> Svetlana Degtyareva</a>, <a href="https://publications.waset.org/abstracts/search?q=Veronika%20Kanestri"> Veronika Kanestri</a>, <a href="https://publications.waset.org/abstracts/search?q=Danila%20Konnov"> Danila Konnov</a> </p> <p class="card-text"><strong>Abstract:</strong></p> An adequate choice of the initial antiretroviral treatment determines the treatment efficacy. In the clinical guidelines in Russia non-nucleoside reverse transcriptase inhibitors (NNRTIs) are still considered to be an option for first-line treatment while pretreatment drug resistance (PDR) testing is not routinely performed. We conducted a cohort retrospective study in HIV-positive treatment naïve patients of the H-clinic (Moscow, Russia) who performed PDR testing from July 2017 to November 2021. All the information was obtained from the medical records anonymously. We analyzed the mutations in reverse transcriptase and protease genes. RT-sequences were obtained by AmpliSens HIV-Resist-Seq kit. Drug resistance was defined using the HIVdb Program v. 8.9-1. PDR was estimated using the Stanford algorithm. Descriptive statistics were performed in Excel (Microsoft Office, 2019). A total of 261 HIV-1 infected patients were enrolled in the study including 197 (75.5%) male and 64 (24.5%) female. The mean age was 34.6±8.3 years. The median CD4 count – 521 cells/µl (IQR 367-687 cells/µl). Data on risk factors of HIV-infection were scarce. The total quantity of strains containing mutations in the reverse transcriptase gene was 75 (28.7%). From these 5 (1.9%) mutations were associated with PDR to nucleoside reverse transcriptase inhibitors (NRTIs) and 30 (11.5%) – with PDR to NNRTIs. The number of strains with mutations in protease gene was 43 (16.5%), from these only 3 (1.1%) mutations were associated with resistance to protease inhibitors. For NNRTIs the most prevalent PDR mutations were E138A, V106I. Most of the HIV variants exhibited a single PDR mutation, 2 were found in 3 samples. Most of HIV variants with PDR mutation displayed a single drug class resistance mutation. 2/37 (5.4%) strains had both NRTIs and NNRTIs mutations. There were no strains identified with PDR mutations to all three drug classes. Though earlier data demonstrated a lower level of PDR in HIV treatment naïve population in Russia and our cohort can be not fully representative as it is taken from the private clinic, it reflects the trend of increasing PDR especially to NNRTIs. Therefore, we consider either pretreatment testing or giving the priority to other drugs as first-line treatment necessary. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=HIV" title="HIV">HIV</a>, <a href="https://publications.waset.org/abstracts/search?q=resistance" title=" resistance"> resistance</a>, <a href="https://publications.waset.org/abstracts/search?q=mutations" title=" mutations"> mutations</a>, <a href="https://publications.waset.org/abstracts/search?q=treatment" title=" treatment"> treatment</a> </p> <a href="https://publications.waset.org/abstracts/152294/prevalence-of-pretreatment-drug-hiv-1-mutations-in-moscow-russia" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/152294.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">94</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3219</span> Evaluation of Brca1/2 Mutational Status among Algerian Familial Breast Cancer</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Arab%20M.">Arab M.</a>, <a href="https://publications.waset.org/abstracts/search?q=Ait%20Abdallah%20M."> Ait Abdallah M.</a>, <a href="https://publications.waset.org/abstracts/search?q=Zeraoulia%20N."> Zeraoulia N.</a>, <a href="https://publications.waset.org/abstracts/search?q=Boumaza%20H."> Boumaza H.</a>, <a href="https://publications.waset.org/abstracts/search?q=Aoutia%20M."> Aoutia M.</a>, <a href="https://publications.waset.org/abstracts/search?q=Griene%20L."> Griene L.</a>, <a href="https://publications.waset.org/abstracts/search?q=Ait%20Abdelkader%20B."> Ait Abdelkader B.</a>, <a href="https://publications.waset.org/abstracts/search?q="></a> </p> <p class="card-text"><strong>Abstract:</strong></p> breast and ovarian cancer are respectively the first and fourth leading causes of cancer among women in Algeria. A family story of cancer in the most important risk factor, and in most cases of families with breast and /or ovarian cancer, the pattern of cancer family can be attributed to mutation in BRCA1/2genes. objectibes: the aim of our study in to investigate the spectrum of BRCA1/2 germiline mutation in familial breast and /or ovarian cancer and to determine the prevalence and the nature of BRCA1/2mutation in Algeria methods: we deremined the prevalence of BRCA1/2 mutation within a cohort of 161 probands selected according the eisinger score double stranded sanger sequencing of all coding exons of BRCA1/2including flanking intronic region were performed results: we identified a total of 23 distinct deleterious mutations (class5) 12 differents mutations in BRCA1(52%) and 11 in BRCA2(48%). 78% (18/23) were protein truncating and 22%(5/23) missens mutations.3 novel deleterious mutations have been identified, which have not been described in public mutation database. one new mutation were found in two unrelated patients. the overall mutation detection rate in our study is 28,5%(46/161).more over, an UVS c7783 located in BRCA2 is found in two unrelated probands and segregate in the 02 families/ conclusion: our results sugget of large spectrum of BRCA1/2 mutation in Algerian breast/ovarian cancer family. The nature and prevalence of BRCA1/2mutation in algerian families are ongoing in a larger study, 80 probands are to day under investigation. This study which may therefore identify the genetic particularity of Algerian breast /ovarian cancer. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=BRCA1%2F2%20mutations" title="BRCA1/2 mutations">BRCA1/2 mutations</a>, <a href="https://publications.waset.org/abstracts/search?q=hereditary%20breast%20cancer" title=" hereditary breast cancer"> hereditary breast cancer</a>, <a href="https://publications.waset.org/abstracts/search?q=algerian%20women" title=" algerian women"> algerian women</a>, <a href="https://publications.waset.org/abstracts/search?q=prvalence" title=" prvalence"> prvalence</a> </p> <a href="https://publications.waset.org/abstracts/147348/evaluation-of-brca12-mutational-status-among-algerian-familial-breast-cancer" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/147348.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">175</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3218</span> Automated Java Testing: JUnit versus AspectJ</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Manish%20Jain">Manish Jain</a>, <a href="https://publications.waset.org/abstracts/search?q=Dinesh%20Gopalani"> Dinesh Gopalani</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Growing dependency of mankind on software technology increases the need for thorough testing of the software applications and automated testing techniques that support testing activities. We have outlined our testing strategy for performing various types of automated testing of Java applications using AspectJ which has become the de-facto standard for Aspect Oriented Programming (AOP). Likewise JUnit, a unit testing framework is the most popular Java testing tool. In this paper, we have evaluated our proposed AOP approach for automated testing and JUnit on various parameters. First we have provided the similarity between the two approaches and then we have done a detailed comparison of the two testing techniques on factors like lines of testing code, learning curve, testing of private members etc. We established that our AOP testing approach using AspectJ has got several advantages and is thus particularly more effective than JUnit. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=aspect%20oriented%20programming" title="aspect oriented programming">aspect oriented programming</a>, <a href="https://publications.waset.org/abstracts/search?q=AspectJ" title=" AspectJ"> AspectJ</a>, <a href="https://publications.waset.org/abstracts/search?q=aspects" title=" aspects"> aspects</a>, <a href="https://publications.waset.org/abstracts/search?q=JU-nit" title=" JU-nit"> JU-nit</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title=" software testing"> software testing</a> </p> <a href="https://publications.waset.org/abstracts/82341/automated-java-testing-junit-versus-aspectj" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/82341.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">331</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3217</span> Comparing Accuracy of Semantic and Radiomics Features in Prognosis of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Mahya%20Naghipoor">Mahya Naghipoor</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Purpose: Non-small cell lung cancer (NSCLC) is the most common lung cancer type. Epidermal growth factor receptor (EGFR) mutation is the main reason which causes NSCLC. Computed tomography (CT) is used for diagnosis and prognosis of lung cancers because of low price and little invasion. Semantic analyses of qualitative CT features are based on visual evaluation by radiologist. However, the naked eye ability may not assess all image features. On the other hand, radiomics provides the opportunity of quantitative analyses for CT images features. The aim of this review study was comparing accuracy of semantic and radiomics features in prognosis of EGFR mutation in NSCLC. Methods: For this purpose, the keywords including: non-small cell lung cancer, epidermal growth factor receptor mutation, semantic, radiomics, feature, receiver operating characteristics curve (ROC) and area under curve (AUC) were searched in PubMed and Google Scholar. Totally 29 papers were reviewed and the AUC of ROC analyses for semantic and radiomics features were compared. Results: The results showed that the reported AUC amounts for semantic features (ground glass opacity, shape, margins, lesion density and presence or absence of air bronchogram, emphysema and pleural effusion) were %41-%79. For radiomics features (kurtosis, skewness, entropy, texture, standard deviation (SD) and wavelet) the AUC values were found %50-%86. Conclusions: In conclusion, the accuracy of radiomics analysis is a little higher than semantic in prognosis of EGFR mutation in NSCLC. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=lung%20cancer" title="lung cancer">lung cancer</a>, <a href="https://publications.waset.org/abstracts/search?q=radiomics" title=" radiomics"> radiomics</a>, <a href="https://publications.waset.org/abstracts/search?q=computer%20tomography" title=" computer tomography"> computer tomography</a>, <a href="https://publications.waset.org/abstracts/search?q=mutation" title=" mutation "> mutation </a> </p> <a href="https://publications.waset.org/abstracts/124165/comparing-accuracy-of-semantic-and-radiomics-features-in-prognosis-of-epidermal-growth-factor-receptor-mutation-in-non-small-cell-lung-cancer" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/124165.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">167</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3216</span> In silico Analysis of a Causative Mutation in Cadherin-23 Gene Identified in an Omani Family with Hearing Loss</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Mohammed%20N.%20Al%20Kindi">Mohammed N. Al Kindi</a>, <a href="https://publications.waset.org/abstracts/search?q=Mazin%20Al%20Khabouri"> Mazin Al Khabouri</a>, <a href="https://publications.waset.org/abstracts/search?q=Khalsa%20Al%20Lamki"> Khalsa Al Lamki</a>, <a href="https://publications.waset.org/abstracts/search?q=Tommasso%20Pappuci"> Tommasso Pappuci</a>, <a href="https://publications.waset.org/abstracts/search?q=Giovani%20Romeo"> Giovani Romeo</a>, <a href="https://publications.waset.org/abstracts/search?q=Nadia%20Al%20Wardy"> Nadia Al Wardy</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Hereditary hearing loss is a heterogeneous group of complex disorders with an overall incidence of one in every five hundred newborns presented as syndromic and non-syndromic forms. Cadherin-related 23 (CDH23) is one of the listed deafness causative genes. CDH23 is found to be expressed in the stereocilia of hair cells and the retina photoreceptor cells. Defective CDH23 has been associated mostly with prelingual severe-to-profound sensorineural hearing loss (SNHL) in either syndromic (USH1D) or non-syndromic SNHL (DFNB12). An Omani family diagnosed clinically with severe-profound sensorineural hearing loss was genetically analysed by whole exome sequencing technique. A novel homozygous missense variant, c.A7451C (p.D2484A), in exon 53 of CDH23 was detected. One hundred and thirty control samples were analysed where all were negative for the detected variant. The variant was analysed in silico for pathogenicity verification using several mutation prediction software. The variant proved to be a pathogenic mutation and is reported for the first time in Oman and worldwide. It is concluded that in silico mutation prediction analysis might be used as a useful molecular diagnostics tool benefiting both genetic counseling and mutation verification. The aspartic acid 2484 alanine missense substitution might be the main disease-causing mutation that damages CDH23 function and could be used as a genetic hearing loss marker for this particular Omani family. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=Cdh23" title="Cdh23">Cdh23</a>, <a href="https://publications.waset.org/abstracts/search?q=d2484a" title=" d2484a"> d2484a</a>, <a href="https://publications.waset.org/abstracts/search?q=in%20silico" title=" in silico"> in silico</a>, <a href="https://publications.waset.org/abstracts/search?q=Oman" title=" Oman"> Oman</a> </p> <a href="https://publications.waset.org/abstracts/80209/in-silico-analysis-of-a-causative-mutation-in-cadherin-23-gene-identified-in-an-omani-family-with-hearing-loss" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/80209.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">216</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3215</span> Mutation of Galp Improved Fermentation of Mixed Sugars to Succinate Using Engineered Escherichia coli As1600a </h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Apichai%20Sawisit">Apichai Sawisit</a>, <a href="https://publications.waset.org/abstracts/search?q=Sirima%20Suvarnakuta%20Jantama"> Sirima Suvarnakuta Jantama</a>, <a href="https://publications.waset.org/abstracts/search?q=Sunthorn%20Kanchanatawee"> Sunthorn Kanchanatawee</a>, <a href="https://publications.waset.org/abstracts/search?q=Lonnie%20O.%20Ingram"> Lonnie O. Ingram</a>, <a href="https://publications.waset.org/abstracts/search?q=Kaemwich%20Jantama"> Kaemwich Jantama</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Escherichia coli KJ122 was engineered to produce succinate from glucose using the wild type GalP for glucose uptake instead of the native phosphotransferase system (ptsI mutation). This strain ferments 10% (w/v) xylose poorly. Mutants were selected by serial transfers in AM1 mineral salts medium with 10% (w/v) xylose. Evolved mutants exhibited a similar improvement, co-fermentation of an equal mixture of xylose and glucose. One of these, AS1600a, produced 84.26±1.37 g/L succinate, equivalent to that produced by the parent (KJ122) strain from 10% glucose (85.46±1.78 g/L). AS1600a was sequenced and found to contain a mutation in galactose permease (GalP, G236D). Expressing the galP* mutation gene in KJ122ΔgalP resembled the xylose utilization phenotype of the mutant AS1600a. The strain AS1600a and KJ122ΔgalP (pLOI5746; galP*) also co-fermented a mixture of glucose, xylose, arabinose, and galactose in sugarcane bagasse hydrolysate for succinate production. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=xylose" title="xylose">xylose</a>, <a href="https://publications.waset.org/abstracts/search?q=furfural" title=" furfural"> furfural</a>, <a href="https://publications.waset.org/abstracts/search?q=succinat" title=" succinat"> succinat</a>, <a href="https://publications.waset.org/abstracts/search?q=sugarcane%20bagasse" title=" sugarcane bagasse"> sugarcane bagasse</a>, <a href="https://publications.waset.org/abstracts/search?q=E.%20coli" title=" E. coli "> E. coli </a> </p> <a href="https://publications.waset.org/abstracts/46871/mutation-of-galp-improved-fermentation-of-mixed-sugars-to-succinate-using-engineered-escherichia-coli-as1600a" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/46871.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">450</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3214</span> Study of the Genes Involved in the Resistance of Nosocomial Pseudomonas aeruginosa to Fluoroquinolone</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Rosetta%20Moshirian%20Farahi">Rosetta Moshirian Farahi</a>, <a href="https://publications.waset.org/abstracts/search?q=Ahya%20Abdi%20Ali"> Ahya Abdi Ali</a>, <a href="https://publications.waset.org/abstracts/search?q=Sara%20Gharavi"> Sara Gharavi </a> </p> <p class="card-text"><strong>Abstract:</strong></p> The major mechanism of Pseudomonas aeruginosa resistance to fluoroquinolones is the alteration of target enzymes, type II and IV topoisomerases due to mutations in the quinolone resistance-determining regions (QRDR) of the gyrA and parC genes coding A subunits of these enzymes. 37 isolates from patients with burn wounds and 20 isolates from blood, urine and sputum specimen were selected to evaluate mutations involved in antibiotic resistance and were subsequently verified for their resistance to ciprofloxacin. QRDRs regions of gyrA and parC were amplified by polymerase chain reaction (PCR) and were subsequently sequenced. 90% of isolates with MIC≥8 µg/ml to ciprofloxacin had a mutation in gyrA gene in which threonine at position 83 changed to isoleucine. 87.5% of isolates had mutation in parC, Serine 87 changed. 75% had Ser87Leu and 12.5% possessed Serin87Trp. Various silent mutations were also detected such as Val103Val, Ala118Ala, Ala136Ala, His132His in gyrA and Ala115Ala in parC. The data indicates that the common mutation in gyrA is Thr83Ile and in parC is Ser87Leu/Trp. No individual parC mutation was observed while mutations in gyrA and parC occurred simultaneously and appears to be the main reason of high-level resistance to fluoroquinolones in patients with burn wounds and urine infection. The vast majority of P.aeruginosa isolates had mutation in parC which can play a crucial role in increased resistance of these isolates. This is a report of parC mutations from resistant P. aeruginosa isolates from Iran, Tehran. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=P.%20aeruginosa" title="P. aeruginosa">P. aeruginosa</a>, <a href="https://publications.waset.org/abstracts/search?q=fluoroquinolones" title=" fluoroquinolones"> fluoroquinolones</a>, <a href="https://publications.waset.org/abstracts/search?q=gyrA" title=" gyrA"> gyrA</a>, <a href="https://publications.waset.org/abstracts/search?q=parC" title=" parC"> parC</a>, <a href="https://publications.waset.org/abstracts/search?q=antibiotic%20resistance" title=" antibiotic resistance "> antibiotic resistance </a> </p> <a href="https://publications.waset.org/abstracts/48488/study-of-the-genes-involved-in-the-resistance-of-nosocomial-pseudomonas-aeruginosa-to-fluoroquinolone" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/48488.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">293</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3213</span> Thrombophilic Mutations in Tunisian Patients with Recurrent Pregnancy Loss</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Frikha%20Rim">Frikha Rim</a>, <a href="https://publications.waset.org/abstracts/search?q=Abdelmoula%20Bouayed%20Nouha"> Abdelmoula Bouayed Nouha</a>, <a href="https://publications.waset.org/abstracts/search?q=Rebai%20Tarek"> Rebai Tarek</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Pregnancy is a hypercoagulable state which causing a defective maternal haemostatic response and leading to thrombosis of the uteroplacental vasculature, that might cause pregnancy complications as recurrent pregnancy loss (RPL). Since heritable Thrombophilic defects are associated with increased thrombosis, their prevalence was evaluated in patients with special emphasis on combinations of the above pathologies. Especially, Factor V Leiden (FVL) G1691A, methylene tetra hydro folate reductase (MTHFR) C677T, and factor II (FII) G20210A mutations are three important causes of thrombophilia, which might be related to recurrent pregnancy loss (RPL). In this study we evaluated the presence of these three mutations [factor V Leiden (FVL), prothrombin G20210A (PTG) and methylenetetrahydrofolate reductase (MTHFR) C677T] amongst 35 Tunisian women with more than 2 miscarriages, referred to our genetic counseling. DNA was extracted from peripheral blood samples and PCR-RFLP was performed for the molecular diagnosis of each mutation. Factor V Leiden and Prothrombin mutation were detected respectively in 5.7% and 2.9% of women with particular history of early fetal loss and thrombotic events. Despites the luck of strength of this study, we insist that testing for the most inherited thrombophilia (FVL and FII mutation) should be performed in women with RPL in the context of thrombotic events. Multi-centre collaboration is necessary to clarify the real impact of thrombotic molecular defects on the pregnancy outcome, to ascertain the effect of thrombophilia on recurrent pregnancy loss and then to evaluate the appropriate therapeutic approach. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=thrombophilia" title="thrombophilia">thrombophilia</a>, <a href="https://publications.waset.org/abstracts/search?q=recurrent%20pregnancy%20loss" title=" recurrent pregnancy loss"> recurrent pregnancy loss</a>, <a href="https://publications.waset.org/abstracts/search?q=factor%20V%20Leiden" title=" factor V Leiden"> factor V Leiden</a>, <a href="https://publications.waset.org/abstracts/search?q=prothrombin%20G20210A" title=" prothrombin G20210A"> prothrombin G20210A</a>, <a href="https://publications.waset.org/abstracts/search?q=methylene%20tetra%20hydro%20folate%20reductase" title=" methylene tetra hydro folate reductase"> methylene tetra hydro folate reductase</a> </p> <a href="https://publications.waset.org/abstracts/18319/thrombophilic-mutations-in-tunisian-patients-with-recurrent-pregnancy-loss" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/18319.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">458</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3212</span> MSIpred: A Python 2 Package for the Classification of Tumor Microsatellite Instability from Tumor Mutation Annotation Data Using a Support Vector Machine</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Chen%20Wang">Chen Wang</a>, <a href="https://publications.waset.org/abstracts/search?q=Chun%20Liang"> Chun Liang</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Microsatellite instability (MSI) is characterized by high degree of polymorphism in microsatellite (MS) length due to a deficiency in mismatch repair (MMR) system. MSI is associated with several tumor types and its status can be considered as an important indicator for tumor prognostic. Conventional clinical diagnosis of MSI examines PCR products of a panel of MS markers using electrophoresis (MSI-PCR) which is laborious, time consuming, and less reliable. MSIpred, a python 2 package for automatic classification of MSI was released by this study. It computes important somatic mutation features from files in mutation annotation format (MAF) generated from paired tumor-normal exome sequencing data, subsequently using these to predict tumor MSI status with a support vector machine (SVM) classifier trained by MAF files of 1074 tumors belonging to four types. Evaluation of MSIpred on an independent 358-tumor test set achieved overall accuracy of over 98% and area under receiver operating characteristic (ROC) curve of 0.967. These results indicated that MSIpred is a robust pan-cancer MSI classification tool and can serve as a complementary diagnostic to MSI-PCR in MSI diagnosis. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=microsatellite%20instability" title="microsatellite instability">microsatellite instability</a>, <a href="https://publications.waset.org/abstracts/search?q=pan-cancer%20classification" title=" pan-cancer classification"> pan-cancer classification</a>, <a href="https://publications.waset.org/abstracts/search?q=somatic%20mutation" title=" somatic mutation"> somatic mutation</a>, <a href="https://publications.waset.org/abstracts/search?q=support%20vector%20machine" title=" support vector machine"> support vector machine</a> </p> <a href="https://publications.waset.org/abstracts/93236/msipred-a-python-2-package-for-the-classification-of-tumor-microsatellite-instability-from-tumor-mutation-annotation-data-using-a-support-vector-machine" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/93236.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">173</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3211</span> Mutational Analysis of JAK2V617F in Tunisian CML Patients with TKI-Resistance</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=R.%20Frikha">R. Frikha</a>, <a href="https://publications.waset.org/abstracts/search?q=H.%20Kamoun"> H. Kamoun</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Background:Chronicmyeloidleukemia (CML), a hematologicaldisease, ischaracterized by t (9; 22) and relatedoncogene BCR-ABL formation. Although Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of CML, resistanceoccurs and possibly médiates by mutation in severalgenesindependently of the bcr-abl1 kinase mechanism. it has been reportedthat JAK2V617F/BCR-ABL double positivitymaybe a potential marker of resistance in CML. Aims: This studywasinvestigated the JAK2V617F mutation in TKI-resistant CML patients. Methods: A retrospectivestudywasconducted in the Hospital University of Sfax, south of Tunisia, including all CML TKI-resistant patients. A Sanger sequencingwasperformedusing a high-fidelity DNA polymerase. Results:Nineresistant CP-CML patients wereenrolled in thisstudy. The JAK2V617F mutation wasdetectedin 3 patients with TKI resistance. Conclusion:Despite the limit of ourstudy, ourfinding highlights the high frequency of JAK2V617F/BCR-ABL double positivity as an important marker of resistance. So; the combination of JAK and TKI inhibitorsmightbe effective and potentiallybeguided by molecular monitoring of minimal residual disease1. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=chronic%20myeloid%20leukemia" title="chronic myeloid leukemia">chronic myeloid leukemia</a>, <a href="https://publications.waset.org/abstracts/search?q=tyrosine%20kinase%20inhibitors" title=" tyrosine kinase inhibitors"> tyrosine kinase inhibitors</a>, <a href="https://publications.waset.org/abstracts/search?q=resistance" title=" resistance"> resistance</a>, <a href="https://publications.waset.org/abstracts/search?q=JAK2V617F" title=" JAK2V617F"> JAK2V617F</a>, <a href="https://publications.waset.org/abstracts/search?q=BCR-ABL" title=" BCR-ABL"> BCR-ABL</a> </p> <a href="https://publications.waset.org/abstracts/174877/mutational-analysis-of-jak2v617f-in-tunisian-cml-patients-with-tki-resistance" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/174877.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">67</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3210</span> Analyzing the Effectiveness of Different Testing Techniques in Ensuring Software Quality</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=R.%20M.%20P.%20C.%20Bandara">R. M. P. C. Bandara</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20L.%20L.%20Weerasinghe"> M. L. L. Weerasinghe</a>, <a href="https://publications.waset.org/abstracts/search?q=K.%20T.%20C.%20R.%20Kumari"> K. T. C. R. Kumari</a>, <a href="https://publications.waset.org/abstracts/search?q=A.%20G.%20D.%20R.%20Hansika"> A. G. D. R. Hansika</a>, <a href="https://publications.waset.org/abstracts/search?q=D.%20I.%20De%20Silva"> D. I. De Silva</a>, <a href="https://publications.waset.org/abstracts/search?q=D.%20M.%20T.%20H.%20Dias"> D. M. T. H. Dias</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Software testing is an essential process in software development that aims to identify defects and ensure that software is functioning as intended. Various testing techniques are employed to achieve this goal, but the effectiveness of these techniques varies. This research paper analyzes the effectiveness of different testing techniques in ensuring software quality. The paper explores different testing techniques, including manual and automated testing, and evaluates their effectiveness in terms of identifying defects, reducing the number of defects in software, and ensuring that software meets its functional and non-functional requirements. Moreover, the paper will also investigate the impact of factors such as testing time, test coverage, and testing environment on the effectiveness of these techniques. This research aims to provide valuable insights into the effectiveness of different testing techniques, enabling software development teams to make informed decisions about the testing approach that is best suited to their needs. By improving testing techniques, the number of defects in software can be reduced, enhancing the quality of software and ultimately providing better software for users. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=software%20testing%20life%20cycle" title="software testing life cycle">software testing life cycle</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing%20techniques" title=" software testing techniques"> software testing techniques</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing%20strategies" title=" software testing strategies"> software testing strategies</a>, <a href="https://publications.waset.org/abstracts/search?q=effectiveness" title=" effectiveness"> effectiveness</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20quality" title=" software quality"> software quality</a> </p> <a href="https://publications.waset.org/abstracts/166772/analyzing-the-effectiveness-of-different-testing-techniques-in-ensuring-software-quality" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/166772.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">84</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3209</span> Rare DCDC2 Mutation Causing Renal-Hepatic Ciliopathy</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Atitallah%20Sofien">Atitallah Sofien</a>, <a href="https://publications.waset.org/abstracts/search?q=Bouyahia%20Olfa"> Bouyahia Olfa</a>, <a href="https://publications.waset.org/abstracts/search?q=Attar%20Souleima"> Attar Souleima</a>, <a href="https://publications.waset.org/abstracts/search?q=Missaoui%20Nada"> Missaoui Nada</a>, <a href="https://publications.waset.org/abstracts/search?q=Ben%20Rabeh%20Rania"> Ben Rabeh Rania</a>, <a href="https://publications.waset.org/abstracts/search?q=Yahyaoui%20Salem"> Yahyaoui Salem</a>, <a href="https://publications.waset.org/abstracts/search?q=Mazigh%20Sonia"> Mazigh Sonia</a>, <a href="https://publications.waset.org/abstracts/search?q=Boukthir%20Samir"> Boukthir Samir</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Introduction: Ciliopathies are a spectrum of diseases that have in common a defect in the synthesis of ciliary proteins. It is a rare cause of neonatal cholestasis. Clinical presentation varies extremely, and the main affected organs are the kidneys, liver, and pancreas. Methodology: This is a descriptive case report of a newborn who was admitted for exploration of neonatal cholestasis in the Paediatric Department C at the Children’s Hospital of Tunis, where the investigations concluded with a rare genetic mutation. Results: This is the case of a newborn male with no family history of hepatic and renal diseases, born to consanguineous parents, and from a well-monitored uneventful pregnancy. He developed jaundice on the second day of life, for which he received conventional phototherapy in the neonatal intensive care unit. He was admitted at 15 days for mild bronchiolitis. On clinical examination, intense jaundice was noted with normal stool and urine colour. Initial blood work showed an elevation in conjugated bilirubin and a high gamma-glutamyl transferase level. Transaminases and prothrombin time were normal. Abdominal sonography revealed hepatomegaly, splenomegaly, and undifferentiated renal cortex with bilateral medullar micro-cysts. Kidney function tests were normal. The infant received ursodeoxycholic acid and vitamin therapy. Genetic testing showed a homozygous mutation in the DCDC2 gene that hadn’t been documented before confirming the diagnosis of renal-hepatic ciliopathy. The patient has regular follow-ups, and his conjugated bilirubin and gamma-glutamyl transferase levels have been decreasing. Conclusion: Genetic testing has revolutionized the approach to etiological diagnosis in pediatric cholestasis. It enables personalised treatment strategies to better enhance the quality of life of patients and prevent potential complications following adequate long-term monitoring. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=cholestasis" title="cholestasis">cholestasis</a>, <a href="https://publications.waset.org/abstracts/search?q=newborn" title=" newborn"> newborn</a>, <a href="https://publications.waset.org/abstracts/search?q=ciliopathy" title=" ciliopathy"> ciliopathy</a>, <a href="https://publications.waset.org/abstracts/search?q=DCDC2" title=" DCDC2"> DCDC2</a>, <a href="https://publications.waset.org/abstracts/search?q=genetic" title=" genetic"> genetic</a> </p> <a href="https://publications.waset.org/abstracts/175773/rare-dcdc2-mutation-causing-renal-hepatic-ciliopathy" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/175773.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">63</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3208</span> Automated User Story Driven Approach for Web-Based Functional Testing</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Mahawish%20Masud">Mahawish Masud</a>, <a href="https://publications.waset.org/abstracts/search?q=Muhammad%20Iqbal"> Muhammad Iqbal</a>, <a href="https://publications.waset.org/abstracts/search?q=M.%20U.%20Khan"> M. U. Khan</a>, <a href="https://publications.waset.org/abstracts/search?q=Farooque%20Azam"> Farooque Azam</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Manual writing of test cases from functional requirements is a time-consuming task. Such test cases are not only difficult to write but are also challenging to maintain. Test cases can be drawn from the functional requirements that are expressed in natural language. However, manual test case generation is inefficient and subject to errors.  In this paper, we have presented a systematic procedure that could automatically derive test cases from user stories. The user stories are specified in a restricted natural language using a well-defined template.  We have also presented a detailed methodology for writing our test ready user stories. Our tool “Test-o-Matic” automatically generates the test cases by processing the restricted user stories. The generated test cases are executed by using open source Selenium IDE.  We evaluate our approach on a case study, which is an open source web based application. Effectiveness of our approach is evaluated by seeding faults in the open source case study using known mutation operators.  Results show that the test case generation from restricted user stories is a viable approach for automated testing of web applications. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=automated%20testing" title="automated testing">automated testing</a>, <a href="https://publications.waset.org/abstracts/search?q=natural%20language" title=" natural language"> natural language</a>, <a href="https://publications.waset.org/abstracts/search?q=restricted%20user%20story%20modeling" title=" restricted user story modeling"> restricted user story modeling</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20engineering" title=" software engineering"> software engineering</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title=" software testing"> software testing</a>, <a href="https://publications.waset.org/abstracts/search?q=test%20case%20specification" title=" test case specification"> test case specification</a>, <a href="https://publications.waset.org/abstracts/search?q=transformation%20and%20automation" title=" transformation and automation"> transformation and automation</a>, <a href="https://publications.waset.org/abstracts/search?q=user%20story" title=" user story"> user story</a>, <a href="https://publications.waset.org/abstracts/search?q=web%20application%20testing" title=" web application testing"> web application testing</a> </p> <a href="https://publications.waset.org/abstracts/63293/automated-user-story-driven-approach-for-web-based-functional-testing" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/63293.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">387</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3207</span> A Comparative Study of Three Major Performance Testing Tools</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Abdulaziz%20Omar%20Alsadhan">Abdulaziz Omar Alsadhan</a>, <a href="https://publications.waset.org/abstracts/search?q=Mohd%20Mudasir%20Shafi"> Mohd Mudasir Shafi</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Performance testing is done to prove the reliability of any software product. There are a number of tools available in the markets that are used to perform performance testing. In this paper we present a comparative study of the three most commonly used performance testing tools. These tools cover the major share of the performance testing market and are widely used. In this paper we compared the tools on five evaluation parameters which are; User friendliness, portability, tool support, compatibility and cost. The conclusion provided at the end of the paper is based on our study and does not support any tool or company. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=software%20development" title="software development">software development</a>, <a href="https://publications.waset.org/abstracts/search?q=software%20testing" title=" software testing"> software testing</a>, <a href="https://publications.waset.org/abstracts/search?q=quality%20assurance" title=" quality assurance"> quality assurance</a>, <a href="https://publications.waset.org/abstracts/search?q=performance%20testing" title=" performance testing"> performance testing</a>, <a href="https://publications.waset.org/abstracts/search?q=load%20runner" title=" load runner"> load runner</a>, <a href="https://publications.waset.org/abstracts/search?q=rational%20testing" title=" rational testing"> rational testing</a>, <a href="https://publications.waset.org/abstracts/search?q=silk%20performer" title=" silk performer"> silk performer</a> </p> <a href="https://publications.waset.org/abstracts/4106/a-comparative-study-of-three-major-performance-testing-tools" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/4106.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">608</span> </span> </div> </div> <div class="card paper-listing mb-3 mt-3"> <h5 class="card-header" style="font-size:.9rem"><span class="badge badge-info">3206</span> Influence of Genetic Counseling in Family Dynamics in Patients with Deafness in Merida, Yucatán, Mexico</h5> <div class="card-body"> <p class="card-text"><strong>Authors:</strong> <a href="https://publications.waset.org/abstracts/search?q=Damaris%20Estrella%20Castillo">Damaris Estrella Castillo</a>, <a href="https://publications.waset.org/abstracts/search?q=Zacil%20ha%20Vilchis%20Zapata"> Zacil ha Vilchis Zapata</a>, <a href="https://publications.waset.org/abstracts/search?q=Leydi%20Peraza%20G%C3%B3mez"> Leydi Peraza Gómez</a> </p> <p class="card-text"><strong>Abstract:</strong></p> Hearing loss is an etiologically heterogeneous condition, where almost 60% is genetic in origin, 20% is due to environmental factors, and 20% have unknown causes. However, it is now known that the gene, GJB2, which encodes the connexin 26 protein, accounts for a large percentage of non-syndromic genetic hearing loss, and variants in this gene have been identified to be a common cause of hereditary hearing loss in many populations. The literature reports that the etiology in deafness helps improve family functioning but low-income countries this is difficult. Therefore, it is difficult to contribute the right of families to know about the genetic risk in future pregnancies as well as determining the certainty of being a carrier or affected. In order to assess the impact of genetic counseling and the functionality, 100 families with at least one child with profound hearing loss, were evaluated by specialists in audiology, clinical genetics and psychology. Targeted mutation analysis for one of the two known large deletions of upstream of GJB2/GJB6 gene (35delG; and including GJB2 regulatory sequences and GJB6) were performed in patients with diagnosis of non-syndromic hearing loss. Genetic counseling was given to all parents and primary caregivers, and APGAR family test was applied before and after the counseling. We analyzed a total of 300 members (children, parents) to determine the presence of the GJB2 gene mutation. Twelve patients (carriers and affected) were positive for the mutation, from 5 different families. The subsequent family APGAR testing and genetic counseling, showed that 14% perceived their families as functional, 62 % and 24 % moderately functional dysfunctional. This shows the importance of genetic counseling in the perception of family function that can directly impact the quality of life of these families. <p class="card-text"><strong>Keywords:</strong> <a href="https://publications.waset.org/abstracts/search?q=family%20dynamics" title="family dynamics">family dynamics</a>, <a href="https://publications.waset.org/abstracts/search?q=deafness" title=" deafness"> deafness</a>, <a href="https://publications.waset.org/abstracts/search?q=APGAR" title=" APGAR"> APGAR</a>, <a href="https://publications.waset.org/abstracts/search?q=counseling" title=" counseling"> counseling</a> </p> <a href="https://publications.waset.org/abstracts/17887/influence-of-genetic-counseling-in-family-dynamics-in-patients-with-deafness-in-merida-yucatan-mexico" class="btn btn-primary btn-sm">Procedia</a> <a href="https://publications.waset.org/abstracts/17887.pdf" target="_blank" class="btn btn-primary btn-sm">PDF</a> <span class="bg-info text-light px-1 py-1 float-right rounded"> Downloads <span class="badge badge-light">643</span> </span> </div> </div> <ul class="pagination"> <li class="page-item disabled"><span class="page-link">&lsaquo;</span></li> <li class="page-item active"><span class="page-link">1</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=2">2</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=3">3</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=4">4</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=5">5</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=6">6</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=7">7</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=8">8</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=9">9</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=10">10</a></li> <li class="page-item disabled"><span class="page-link">...</span></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=107">107</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=108">108</a></li> <li class="page-item"><a class="page-link" href="https://publications.waset.org/abstracts/search?q=mutation%20testing&page=2" rel="next">&rsaquo;</a></li> </ul> </div> </main> <footer> <div id="infolinks" class="pt-3 pb-2"> <div class="container"> <div style="background-color:#f5f5f5;" class="p-3"> <div class="row"> <div class="col-md-2"> <ul class="list-unstyled"> About <li><a href="https://waset.org/page/support">About Us</a></li> <li><a href="https://waset.org/page/support#legal-information">Legal</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/WASET-16th-foundational-anniversary.pdf">WASET celebrates its 16th foundational anniversary</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Account <li><a href="https://waset.org/profile">My Account</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Explore <li><a href="https://waset.org/disciplines">Disciplines</a></li> <li><a href="https://waset.org/conferences">Conferences</a></li> <li><a href="https://waset.org/conference-programs">Conference Program</a></li> <li><a href="https://waset.org/committees">Committees</a></li> <li><a href="https://publications.waset.org">Publications</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Research <li><a href="https://publications.waset.org/abstracts">Abstracts</a></li> <li><a href="https://publications.waset.org">Periodicals</a></li> <li><a href="https://publications.waset.org/archive">Archive</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Open Science <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Philosophy.pdf">Open Science Philosophy</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Science-Award.pdf">Open Science Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Open-Society-Open-Science-and-Open-Innovation.pdf">Open Innovation</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Postdoctoral-Fellowship-Award.pdf">Postdoctoral Fellowship Award</a></li> <li><a target="_blank" rel="nofollow" href="https://publications.waset.org/static/files/Scholarly-Research-Review.pdf">Scholarly Research Review</a></li> </ul> </div> <div class="col-md-2"> <ul class="list-unstyled"> Support <li><a href="https://waset.org/page/support">Support</a></li> <li><a href="https://waset.org/profile/messages/create">Contact Us</a></li> <li><a href="https://waset.org/profile/messages/create">Report Abuse</a></li> </ul> </div> </div> </div> </div> </div> <div class="container text-center"> <hr style="margin-top:0;margin-bottom:.3rem;"> <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" class="text-muted small">Creative Commons Attribution 4.0 International License</a> <div id="copy" class="mt-2">© 2024 World Academy of Science, Engineering and Technology</div> </div> </footer> <a href="javascript:" id="return-to-top"><i class="fas fa-arrow-up"></i></a> <div class="modal" id="modal-template"> <div class="modal-dialog"> <div class="modal-content"> <div class="row m-0 mt-1"> <div class="col-md-12"> <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">×</span></button> </div> </div> <div class="modal-body"></div> </div> </div> </div> <script src="https://cdn.waset.org/static/plugins/jquery-3.3.1.min.js"></script> <script src="https://cdn.waset.org/static/plugins/bootstrap-4.2.1/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.waset.org/static/js/site.js?v=150220211556"></script> <script> jQuery(document).ready(function() { /*jQuery.get("https://publications.waset.org/xhr/user-menu", function (response) { jQuery('#mainNavMenu').append(response); });*/ jQuery.get({ url: "https://publications.waset.org/xhr/user-menu", cache: false }).then(function(response){ jQuery('#mainNavMenu').append(response); }); }); </script> </body> </html>